Diabetes Research - Insulin, Type I, Type II, Diet, Treatment, Prevention

Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.


Diabetes Research Today

Home

View Latest Issue

Information About Diabetes

Books on Diabetes

Advertising in Research Today

View Other Research Today Publications



Volume 8 (2011), Issue 4 (April)

  1. Central melanocortin receptor agonist reduces hepatic lipogenic gene expression in streptozotocin-induced diabetic mice.
    Life Sci, 88(15): 664-9. [Abstract] [Full-text]
  2. An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development.
    Contemp Clin Trials, 32(3): 324-32. [Abstract] [Full-text]
  3. COACH trial: a randomized controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers: rationale and design.
    Contemp Clin Trials, 32(3): 403-11. [Abstract] [Full-text]
  4. Organizing and delivering diabetes education and self-care support: findings of scoping project.
    J Health Serv Res Policy, 16: 42-9. [Abstract] [Full-text]
  5. Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study.
    Ann Epidemiol, 21(5): 374-81. [Abstract] [Full-text]
  6. Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study.
    Ann Epidemiol, 21(5): 367-73. [Abstract] [Full-text]
  7. Hip circumference and the risk of type 2 diabetes in middle-aged and elderly men and women: the Shanghai women and Shanghai men's health studies.
    Ann Epidemiol, 21(5): 358-66. [Abstract] [Full-text]
  8. Complementary and alternative medicine use among Jordanian patients with diabetes.
    Complement Ther Clin Pract, 17(2): 71-5. [Abstract] [Full-text]
  9. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Liver Int, 31(5): 700-6. [Abstract] [Full-text]
  10. RAGE biology, atherosclerosis and diabetes.
    Clin Sci (Lond), 121(2): 43-55. [Abstract] [Full-text]
  11. Antidiabetic effects of duodenojejunal bypass in an experimental model of diabetes induced by a high-fat diet.
    Br J Surg, 98(5): 686-96. [Abstract] [Full-text]
  12. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results.
    Obes Surg, 21(5): 663-7. [Abstract] [Full-text]
  13. Relation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery disease.
    Am J Cardiol, 107(8): 1144-8. [Abstract] [Full-text]
  14. Glucose-induced endoplasmic reticulum stress is independent of oxidative stress: A mechanistic explanation for the failure of antioxidant therapy in diabetes.
    Free Radic Biol Med, 50(9): 1140-3. [Abstract] [Full-text]
  15. Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.
    Am J Cardiol, 107(8): 1155-62. [Abstract] [Full-text]
  16. Maxillary ulceration resulting from using a rapid maxillary expander in a diabetic patient.
    Angle Orthod, 81(3): 546-50. [Abstract] [Full-text]
  17. Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?
    Arch Physiol Biochem, 117(2): 57-63. [Abstract] [Full-text]
  18. Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters.
    Synapse, 65(6): 457-66. [Abstract] [Full-text]
  19. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
    J Cell Biochem, 112(5): 1259-67. [Abstract] [Full-text]
  20. Capacity of diabetes education programs to provide both diabetes self-management education and to implement diabetes prevention services.
    J Public Health Manag Pract, 17(3): 242-7. [Abstract] [Full-text]
  21. Diabetes prevention and control in the workplace: a pilot project for county employees.
    J Public Health Manag Pract, 17(3): 233-41. [Abstract] [Full-text]
  22. HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse.
    Eur J Pharmacol, 658(2): 257-62. [Abstract] [Full-text]
  23. Marine food pollutants as a risk factor for hypoinsulinemia and type 2 diabetes.
    Epidemiology, 22(3): 410-7. [Abstract] [Full-text]
  24. Boiled coffee intake and subsequent risk for type 2 diabetes.
    Epidemiology, 22(3): 418-21. [Abstract] [Full-text]
  25. Cost of diabetes and its complications in Thailand: a complete picture of economic burden.
    Health Soc Care Community, 19(3): 289-98. [Abstract] [Full-text]
  26. Long work hours is associated with suboptimal glycemic control among US workers with diabetes.
    Am J Ind Med, 54(5): 375-83. [Abstract] [Full-text]
  27. Haemostatic and cytokine changes in gestational diabetes mellitus.
    Gynecol Endocrinol, 27(5): 356-60. [Abstract] [Full-text]
  28. Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes.
    Gynecol Endocrinol, 27(5): 361-7. [Abstract] [Full-text]
  29. Effect of glucopyranosylidene-spiro-thiohydantoin on glycogen metabolism in liver tissues of streptozotocin-induced and obese diabetic rats.
    Mol Med Report, 4(3): 477-81. [Abstract] [Full-text]
  30. Hepatic gene expression of the insulin signaling pathway is altered by administration of persimmon peel extract: a DNA microarray study using type 2 diabetic Goto-Kakizaki rats.
    J Agric Food Chem, 59(7): 3320-9. [Abstract] [Full-text]
  31. Appalachian residents' experiences with and management of multiple morbidity.
    Qual Health Res, 21(5): 601-11. [Abstract] [Full-text]
  32. Coping and resilience in adolescents with type 1 diabetes.
    Child Care Health Dev, 37(3): 335-42. [Abstract] [Full-text]
  33. Adolescent BMI trajectory and risk of diabetes versus coronary disease.
    N Engl J Med, 364(14): 1315-25. [Abstract] [Full-text]
  34. Adolescent BMI trajectory and risk of diabetes versus coronary disease.
    N Engl J Med, 364(14): 1315-25. [Abstract] [Full-text]
  35. Antidepressant use, depression, lifestyle factors, and new-onset diabetes.
    Int Clin Psychopharmacol, 26(3): 159-68. [Abstract] [Full-text]
  36. Uridine correlates with the concentration of fructosamine and HbA1c in children with type 1 diabetes.
    Acta Paediatr, 100(5): 712-6. [Abstract] [Full-text]
  37. Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes.
    Clin Endocrinol (Oxf), 74(5): 624-30. [Abstract] [Full-text]
  38. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
    Clin Endocrinol (Oxf), 74(5): 587-92. [Abstract] [Full-text]
  39. Antepartum A1C, maternal diabetes outcomes, and selected offspring outcomes: an epidemiological review.
    Paediatr Perinat Epidemiol, 25(3): 265-76. [Abstract] [Full-text]
  40. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
    J Med Chem, 54(7): 2433-46. [Abstract] [Full-text]
  41. The anterior chamber of the eye as a clinical transplantation site for the treatment of diabetes: a study in a baboon model of diabetes.
    Diabetologia, 54(5): 1121-6. [Abstract] [Full-text]
  42. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.
    Diabetologia, 54(5): 1136-46. [Abstract] [Full-text]
  43. The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
    Diabetologia, 54(5): 1098-108. [Abstract] [Full-text]
  44. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study.
    Diabetologia, 54(5): 1019-24. [Abstract] [Full-text]
  45. Stratification of foot risk predicts the incidence of new foot disease, but do we yet know that the adoption of routine screening reduces it?
    Diabetologia, 54(5): 991-3. [Abstract] [Full-text]
  46. The quasi-linear viscoelastic properties of diabetic and non-diabetic plantar soft tissue.
    Ann Biomed Eng, 39(5): 1517-27. [Abstract] [Full-text]
  47. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
    Diabetologia, 54(5): 1227-41. [Abstract] [Full-text]
  48. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.
    Diabetologia, 54(5): 1032-42. [Abstract] [Full-text]
  49. Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS).
    Diabetologia, 54(5): 1025-31. [Abstract] [Full-text]
  50. Influence of diabetes on endothelial cell response during sepsis.
    Diabetologia, 54(5): 996-1003. [Abstract] [Full-text]
  51. Opposing effects of NaCl restriction and carbohydrate loading on urine volume in diabetic rats.
    Acta Physiol (Oxf), 202(1): 47-57. [Abstract] [Full-text]
  52. Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies.
    Diabetologia, 54(5): 1013-8. [Abstract] [Full-text]
  53. Defects in beta cell Ca²+ signalling, glucose metabolism and insulin secretion in a murine model of K(ATP) channel-induced neonatal diabetes mellitus.
    Diabetologia, 54(5): 1087-97. [Abstract] [Full-text]
  54. Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice.
    Diabetologia, 54(5): 1242-51. [Abstract] [Full-text]
  55. Type 2 diabetes risk allele near CENTD2 is associated with decreased glucose-stimulated insulin release.
    Diabetologia, 54(5): 1052-6. [Abstract] [Full-text]
  56. Risk stratification systems for diabetic foot ulcers: a systematic review.
    Diabetologia, 54(5): 1190-9. [Abstract] [Full-text]
  57. Can one question be a useful indicator of psychosocial problems in adolescents with diabetes mellitus?
    Acta Paediatr, 100(5): 708-11. [Abstract] [Full-text]
  58. Mechanical properties of achilles tendon in rats induced to experimental diabetes.
    Ann Biomed Eng, 39(5): 1528-34. [Abstract] [Full-text]
  59. The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes.
    Diabetologia, 54(5): 1004-12. [Abstract] [Full-text]
  60. Relationship between type 1 diabetes and atopic diseases in a twin population.
    Allergy, 66(5): 645-7. [Abstract] [Full-text]
  61. Immune and cell therapy in type 1 diabetes: too little too late?
    Expert Opin Biol Ther, 11(5): 609-21. [Abstract] [Full-text]
  62. Proteomic changes in the heart of diet-induced pre-diabetic mice.
    J Proteomics, 74(5): 716-27. [Abstract] [Full-text]
  63. Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats.
    Mol Cell Endocrinol, 337(1): 101-13. [Abstract] [Full-text]
  64. Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab study.
    J Hypertens, 29(5): 953-60. [Abstract] [Full-text]
  65. Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus.
    Angiology, 62(4): 291-5. [Abstract] [Full-text]
  66. Assessment of coronary artery disease and calcified coronary plaque burden by computed tomography in patients with and without diabetes mellitus.
    Eur Radiol, 21(5): 944-53. [Abstract] [Full-text]
  67. Method for liver tissue metabolic profiling study and its application in type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry.
    J Chromatogr B Analyt Technol Biomed Life Sci, 879(13): 961-7. [Abstract] [Full-text]
  68. The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes.
    J Matern Fetal Neonatal Med, 24(5): 723-7. [Abstract] [Full-text]
  69. Altered expression of Ano1 variants in human diabetic gastroparesis.
    J Biol Chem, 286(15): 13393-403. [Abstract] [Full-text]
  70. The reversal of diabetes in rat model using mouse insulin producing cells - a combination approach of tissue engineering and macroencapsulation.
    Acta Biomater, 7(5): 2153-62. [Abstract] [Full-text]
  71. Abnormal subcellular localization of AQP5 and downregulated AQP5 protein in parotid glands of streptozotocin-induced diabetic rats.
    Biochim Biophys Acta, 1810(5): 543-54. [Abstract] [Full-text]
  72. Inflammation of the hypothalamus leads to defective pancreatic islet function.
    J Biol Chem, 286(15): 12870-80. [Abstract] [Full-text]
  73. A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes.
    Biochimie, 93(5): 793-805. [Abstract] [Full-text]
  74. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.
    Stem Cell Rev, 7(2): 342-63. [Abstract] [Full-text]
  75. One-hour post-glucola results and pre-pregnancy body mass index are associated with the need for insulin therapy in women with gestational diabetes.
    J Matern Fetal Neonatal Med, 24(5): 718-22. [Abstract] [Full-text]
  76. Menopausal bone changes and incident fractures in diabetic women: a cohort study.
    Osteoporos Int, 22(5): 1367-76. [Abstract] [Full-text]
  77. Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes.
    Muscle Nerve, 43(5): 652-6. [Abstract] [Full-text]
  78. Factors influencing the outcomes of patients with both coronary artery disease and diabetes enrolled in standard cardiac rehabilitation programs: a literature review.
    J Cardiovasc Nurs, 26(3): 210-7. [Abstract] [Full-text]
  79. Use of dynamic contrast-enhanced magnetic resonance imaging to evaluate the microcirculation of lower extremity muscles in patients with Type 2 diabetes.
    Diabet Med, 28(5): 618-21. [Abstract] [Full-text]
  80. History of foot ulcers increases mortality among patients with diabetes in Northern Thailand.
    Diabet Med, 28(5): 608-11. [Abstract] [Full-text]
  81. External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.
    Diabet Med, 28(5): 599-607. [Abstract] [Full-text]
  82. Temporal trends in diabetes prevalence and key diabetes risk factors in Scotland, 2003-2008.
    Diabet Med, 28(5): 595-8. [Abstract] [Full-text]
  83. The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030.
    Diabet Med, 28(5): 575-82. [Abstract] [Full-text]
  84. What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
    Diabet Med, 28(5): 567-74. [Abstract] [Full-text]
  85. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes.
    Diabet Med, 28(5): 549-59. [Abstract] [Full-text]
  86. Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study.
    Diabet Med, 28(5): 543-8. [Abstract] [Full-text]
  87. Potential of education-based insulin therapy for achievement of good metabolic control: a real-life experience.
    Diabet Med, 28(5): 539-42. [Abstract] [Full-text]
  88. Glycaemic index knowledge and use among African Americans with type 2 diabetes.
    J Adv Nurs, 67(5): 1102-8. [Abstract] [Full-text]
  89. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Circulation, 123(14): 1492-500. [Abstract] [Full-text]
  90. Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults.
    Circulation, 123(14): 1537-44. [Abstract] [Full-text]
  91. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.
    J Exp Med, 208(4): 729-45. [Abstract] [Full-text]
  92. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes.
    J Urol, 185(5): 1828-34. [Abstract] [Full-text]
  93. Hepatocyte nuclear factor 4α gene mutation associated with familial neonatal hyperinsulinism and maturity-onset diabetes of the young.
    J Pediatr, 158(5): 852-4. [Abstract] [Full-text]
  94. Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabetic mice.
    J Ethnopharmacol, 134(3): 961-70. [Abstract] [Full-text]
  95. Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation.
    BJOG, 118(6): 748-54. [Abstract] [Full-text]
  96. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases.
    J Ethnopharmacol, 134(3): 584-607. [Abstract] [Full-text]
  97. Exclusion of patients from quality measurement of diabetes care in the UK pay-for-performance programme.
    Diabet Med, 28(5): 525-31. [Abstract] [Full-text]
  98. A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006/2007.
    Diabet Med, 28(5): 583-9. [Abstract] [Full-text]
  99. The in vivo and in vitro diabetic wound healing effects of a 2-herb formula and its mechanisms of action.
    J Ethnopharmacol, 134(3): 831-8. [Abstract] [Full-text]
  100. Genetic variability of the fructosamine 3-kinase gene in diabetic patients.
    Clin Chem Lab Med, 49(5): 803-8. [Abstract] [Full-text]
  101. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis.
    Diabet Med, 28(5): 508-15. [Abstract] [Full-text]
  102. How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients' self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course.
    Diabet Med, 28(5): 532-8. [Abstract] [Full-text]
  103. Alterations in HbA(1c) with advancing age in subjects with normal glucose tolerance: Chandigarh Urban Diabetes Study (CUDS).
    Diabet Med, 28(5): 590-4. [Abstract] [Full-text]
  104. Cerebral infarction associated with transient visual loss in child with diabetic ketoacidosis.
    Diabet Med, 28(5): 516-8. [Abstract] [Full-text]
  105. Glucose-6-phosphate dehydrogenase deficiency diagnosed in an adolescent with type 1 diabetes mellitus and hemoglobin A1c discordant with blood glucose measurements.
    J Pediatr, 158(5): 849-51. [Abstract] [Full-text]
  106. Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus: report of two cases.
    Clin Neurol Neurosurg, 113(4): 325-9. [Abstract] [Full-text]
  107. Oxygen (O2) kinetics during early recovery from peak exercise in patients with Type 2 diabetes.
    Diabet Med, 28(5): 612-7. [Abstract] [Full-text]
  108. The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes.
    Diabet Med, 28(5): 519-24. [Abstract] [Full-text]
  109. Advanced glycation end-products in myocardium-supported vessels: effects of heart failure and diabetes mellitus.
    J Heart Lung Transplant, 30(5): 558-64. [Abstract] [Full-text]
  110. Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia.
    Diabet Med, 28(5): 560-6. [Abstract] [Full-text]
  111. Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.
    Br J Clin Pharmacol, 71(5): 766-76. [Abstract] [Full-text]
  112. Lean mass and fat mass predict bone mineral density in middle-aged individuals with noninsulin-requiring type 2 diabetes mellitus.
    Clin Endocrinol (Oxf), 74(5): 565-71. [Abstract] [Full-text]
  113. Relation of salivary antioxidant status and cytokine levels to clinical parameters of oral health in pregnant women with diabetes.
    Arch Oral Biol, 56(5): 428-36. [Abstract] [Full-text]
  114. Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial.
    Eur J Appl Physiol, 111(5): 749-56. [Abstract] [Full-text]
  115. Could thiamine pyrophosphate be a regulator of the nitric oxide synthesis in the endothelial cell of diabetic patients?
    Med Hypotheses, 76(5): 629-31. [Abstract] [Full-text]
  116. Diabetes might adversely affect expression and function of interstitial cells in the urinary bladder and urethra in humans: a new mechanism in the development of diabetic lower urinary dysfunction?
    Med Hypotheses, 76(5): 632-4. [Abstract] [Full-text]
  117. Social disparities in internet patient portal use in diabetes: evidence that the digital divide extends beyond access.
    J Am Med Inform Assoc, 18(3): 318-21. [Abstract] [Full-text]
  118. Social but safe? Quality and safety of diabetes-related online social networks.
    J Am Med Inform Assoc, 18(3): 292-7. [Abstract] [Full-text]
  119. Determinants of quality of life in type 2 diabetes population: the inclusion of personality.
    Qual Life Res, 20(4): 551-8. [Abstract] [Full-text]
  120. Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials.
    Int J Clin Pract, 65(5): 602-12. [Abstract] [Full-text]
  121. Changes and predictors for change to thiazolidinedione prescribing in UK primary care following the rosiglitazone safety warning.
    Int J Clin Pract, 65(5): 586-91. [Abstract] [Full-text]
  122. The economics of telemedicine for vitreoretinal diseases.
    Curr Opin Ophthalmol, 22(3): 194-8. [Abstract] [Full-text]
  123. Challenges to establishing nationwide diabetic retinopathy screening programs.
    Curr Opin Ophthalmol, 22(3): 174-9. [Abstract] [Full-text]
  124. Glucose metabolism disorders and the risk of cancer.
    Arch Immunol Ther Exp (Warsz), 59(3): 215-30. [Abstract] [Full-text]
  125. Update on nonsurgical therapy for diabetic macular edema.
    Curr Opin Ophthalmol, 22(3): 185-9. [Abstract] [Full-text]
  126. Mouse models of diabetic nephropathy.
    Curr Opin Nephrol Hypertens, 20(3): 278-84. [Abstract] [Full-text]
  127. Diabetic kidney disease with and without albuminuria.
    Curr Opin Nephrol Hypertens, 20(3): 246-57. [Abstract] [Full-text]
  128. Diabetic nephropathy in humans: pathologic diversity.
    Curr Opin Nephrol Hypertens, 20(3): 285-9. [Abstract] [Full-text]
  129. Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels.
    Ann Hum Genet, 75(3): 370-82. [Abstract] [Full-text]
  130. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
    J Endocrinol, 209(2): 185-91. [Abstract] [Full-text]
  131. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.
    J Gastroenterol Hepatol, 26(5): 858-65. [Abstract] [Full-text]
  132. Neonatal diabetes and insulin pump therapy.
    Arch Dis Child Fetal Neonatal Ed, 96(3): F223-4. [Abstract] [Full-text]
  133. Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing.
    J Surg Res, 167(2): 336-42. [Abstract] [Full-text]
  134. Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus.
    PLoS One, 6(4): e18480. [Abstract] [Full-text]
  135. An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes.
    PLoS One, 6(4): e18411. [Abstract] [Full-text]
  136. Implementation of clinical guidelines for adults with asthma and diabetes: a three-year follow-up evaluation of nursing care.
    J Clin Nurs, 20(9): 1329-38. [Abstract] [Full-text]
  137. Depression, coronary artery disease, type 2 diabetes, metabolic syndrome and quality of life in Taiwanese adults from a cardiovascular department of a major hospital in Southern Taiwan.
    J Clin Nurs, 20(9): 1293-302. [Abstract] [Full-text]
  138. Participants' perceptions of the factors that influence diabetes self-management following a structured education (DAFNE) programme.
    J Clin Nurs, 20(9): 1282-92. [Abstract] [Full-text]
  139. Importance of treatment of skin xerosis in diabetes.
    J Eur Acad Dermatol Venereol, 25(5): 607-9. [Abstract] [Full-text]
  140. Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Curr Med Res Opin, 27(5): 1049-58. [Abstract] [Full-text]
  141. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
    Med Care, 49(5): 511-5. [Abstract] [Full-text]
  142. Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study.
    Curr Med Res Opin, 27(5): 1035-40. [Abstract] [Full-text]
  143. Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial.
    J Clin Nurs, 20(9): 1264-72. [Abstract] [Full-text]
  144. Measuring health-related quality of life in non-complicated diabetes patients may be an effective parameter to assess patients at risk of a more serious disease course: a cross-sectional study of two diabetes outpatient groups.
    J Clin Nurs, 20(9): 1255-63. [Abstract] [Full-text]
  145. Special considerations on the management of Latino patients with type 2 diabetes mellitus.
    Curr Med Res Opin, 27(5): 969-79. [Abstract] [Full-text]
  146. The effect of dehydroepiandrosterone (DHEA) on renal function and metabolism in diabetic rats.
    Steroids, 76(6): 564-70. [Abstract] [Full-text]
  147. Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US.
    Curr Med Res Opin, 27(5): 897-906. [Abstract] [Full-text]
  148. Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries.
    Curr Med Res Opin, 27(5): 887-95. [Abstract] [Full-text]
  149. Metabolic syndrome components and age-related cataract: the Singapore Malay eye study.
    Invest Ophthalmol Vis Sci, 52(5): 2397-404. [Abstract] [Full-text]
  150. Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study.
    J Gen Intern Med, 26(5): 505-11. [Abstract] [Full-text]
  151. Unilateral diaphragmatic paralysis in a diabetic patient: a case of trepopnea.
    J Gen Intern Med, 26(5): 555-8. [Abstract] [Full-text]
  152. Risk factors for dementia in patients over 65 with diabetes.
    Int J Geriatr Psychiatry, 26(7): 749-57. [Abstract] [Full-text]
  153. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.
    Magn Reson Med, 65(5): 1407-15. [Abstract] [Full-text]
  154. Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen.
    Am J Cardiol, 107(9): 1346-52. [Abstract] [Full-text]
  155. Periapical and endodontic status of type 2 diabetic patients in Catalonia, Spain: a cross-sectional study.
    J Endod, 37(5): 598-601. [Abstract] [Full-text]
  156. Are we really active in the prevention of obesity and type 2 diabetes at the community level?
    Nutr Metab Cardiovasc Dis, 21(5): 380-9. [Abstract] [Full-text]
  157. Early reduction of circulating homocysteine levels in Goto-Kakizaki rat, a spontaneous nonobese model of type 2 diabetes.
    Biochim Biophys Acta, 1812(6): 699-702. [Abstract] [Full-text]
  158. Bayesian parameter estimation for characterizing the cyclic variation of echocardiographic backscatter to assess the hearts of asymptomatic type 2 diabetes mellitus subjects.
    Ultrasound Med Biol, 37(5): 805-12. [Abstract] [Full-text]
  159. Identification of gene variants in NOS3, ET-1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjects.
    Biochem Biophys Res Commun, 407(3): 486-90. [Abstract] [Full-text]
  160. Poverty in childhood and adverse health outcomes in adulthood.
    Maturitas, 69(1): 22-6. [Abstract] [Full-text]
  161. Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomia.
    Prenat Diagn, 31(5): 479-83. [Abstract] [Full-text]
  162. Characterization of fetal cardiac structure and function detected by echocardiography in women with normal pregnancy and gestational diabetes mellitus.
    Prenat Diagn, 31(5): 459-65. [Abstract] [Full-text]
  163. Home-based exercise for middle-aged Chinese at diabetic risk: a randomized controlled trial.
    Prev Med, 52(5): 337-43. [Abstract] [Full-text]
  164. Characterization and validation of a streptozotocin-induced diabetes model in the vervet monkey.
    J Pharmacol Toxicol Methods, 63(3): 296-303. [Abstract] [Full-text]
  165. Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats.
    Eur J Pharm Sci, 42(5): 496-502. [Abstract] [Full-text]
  166. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials.
    Am J Hypertens, 24(5): 582-90. [Abstract] [Full-text]
  167. An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism.
    J Biol Chem, 286(16): 14508-15. [Abstract] [Full-text]
  168. Prenatal presentation of transient central diabetes insipidus.
    Eur J Pediatr, 170(5): 653-6. [Abstract] [Full-text]
  169. Adolescents with diabetes and their parents' perceptions of mental health screening, assessment, and feedback.
    Adm Policy Ment Health, 38(3): 181-92. [Abstract] [Full-text]
  170. Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats.
    J Nutr Biochem, 22(5): 418-25. [Abstract] [Full-text]
  171. Propionic acidemia mimicking diabetic ketoacidosis.
    Brain Dev, 33(5): 428-31. [Abstract] [Full-text]
  172. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.
    Eur J Health Econ, 12(3): 219-30. [Abstract] [Full-text]
  173. The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory.
    Nutr Metab Cardiovasc Dis, 21(5): 339-46. [Abstract] [Full-text]
  174. Effect of screening and management of diabetes during pregnancy on stillbirths.
    BMC Public Health, 11: S2. [Abstract] [Full-text]
  175. Do children and adolescents with type 1 diabetes mellitus have a higher frequency of parietal cell antibodies than healthy controls?
    J Pediatr Gastroenterol Nutr, 52(5): 558-62. [Abstract] [Full-text]
  176. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.
    Ann Intern Med, 154(8): 554-9. [Abstract] [Full-text]
  177. Hemoglobin A1c testing alone does not sufficiently identify patients with prediabetes.
    Am J Clin Pathol, 135(5): 674-7. [Abstract] [Full-text]
  178. Translation of family health history questions on cardiovascular disease and type 2 diabetes with implications for Latina health and nursing practice.
    Nurs Clin North Am, 46(2): 207-18, vii. [Abstract] [Full-text]
  179. Effect of tempol on diabetes-induced decreases in retinal blood flow in the mouse.
    Curr Eye Res, 36(5): 456-61. [Abstract] [Full-text]
  180. Effect on motivation, perceived competence, and activation after participation in the ''Ready to Act'' programme for people with screen-detected dysglycaemia: a 1-year randomised controlled trial, Addition-DK.
    Scand J Public Health, 39(3): 262-71. [Abstract] [Full-text]
  181. Specific maternal microchimeric T cells targeting fetal antigens in β cells predispose to auto-immune diabetes in the child.
    J Autoimmun, 36(3): 253-62. [Abstract] [Full-text]
  182. IL-18 is required for self-reactive T cell expansion in NOD mice.
    J Autoimmun, 36(3): 263-77. [Abstract] [Full-text]
  183. Differential impact of diabetes and hypertension in the brain: adverse effects in white matter.
    Neurobiol Dis, 42(3): 446-58. [Abstract] [Full-text]
  184. Circulating interleukin-6 concentrations during and after gestational diabetes mellitus.
    Acta Obstet Gynecol Scand, 90(5): 524-30. [Abstract] [Full-text]
  185. Obesity, diabetes, and the risk of infections diagnosed in hospital and post-discharge infections after cesarean section: a prospective cohort study.
    Acta Obstet Gynecol Scand, 90(5): 501-9. [Abstract] [Full-text]
  186. An analysis of the existing resources in relation to education and treatment of diabetes in four European countries: Estonia, Finland, Ireland, and Lithuania.
    Appl Nurs Res, 24(2): 118-23. [Abstract] [Full-text]
  187. Metformin restores endothelial function in aorta of diabetic rats.
    Br J Pharmacol, 163(2): 424-37. [Abstract] [Full-text]
  188. Effect of S-adenosylmethionine on neointimal formation after balloon injury in obese diabetic rats.
    Cardiovasc Res, 90(2): 383-93. [Abstract] [Full-text]
  189. Treatment of diabetic retinopathy with anti-VEGF drugs.
    Acta Ophthalmol, 89(3): 203-7. [Abstract] [Full-text]
  190. Is bigger better? Macrosomia and psychopathology later in life.
    Obes Rev, 12(5): e405-11. [Abstract] [Full-text]
  191. An exploration of nurses' perceptions regarding the implementation of a best practice guideline on the assessment and management of foot ulcers for people with diabetes.
    Appl Nurs Res, 24(2): 88-93. [Abstract] [Full-text]
  192. Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response.
    Metabolism, 60(5): 594-603. [Abstract] [Full-text]
  193. α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy.
    J Diabetes Complications, 25(3): 193-201. [Abstract] [Full-text]
  194. Dental caries in diabetes mellitus: role of salivary flow rate and minerals.
    J Diabetes Complications, 25(3): 183-6. [Abstract] [Full-text]
  195. Depression and incident lower limb amputations in veterans with diabetes.
    J Diabetes Complications, 25(3): 175-82. [Abstract] [Full-text]
  196. Comparison of some of the physicochemical characteristics of type 2 diabetic and normal human bones: a sample study.
    J Diabetes Complications, 25(3): 187-92. [Abstract] [Full-text]
  197. Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes.
    J Diabetes Complications, 25(3): 151-8. [Abstract] [Full-text]
  198. New onset type 1 diabetes presenting as ketoacidosis simultaneously presenting with autoimmune hyperthyroidism--a case report.
    J Diabetes Complications, 25(3): 208-10. [Abstract] [Full-text]
  199. The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes.
    J Diabetes Complications, 25(3): 159-67. [Abstract] [Full-text]
  200. Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus.
    J Diabetes Complications, 25(3): 143-50. [Abstract] [Full-text]
  201. Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy.
    J Diabetes Complications, 25(3): 168-74. [Abstract] [Full-text]
  202. Association of calpain 10 gene polymorphisms with type 2 diabetes mellitus in Southern Indians.
    Metabolism, 60(5): 681-8. [Abstract] [Full-text]
  203. The importance of glycemic control: how low should we go with HbA1c? Start early, go safe, go low.
    J Diabetes Complications, 25(3): 202-7. [Abstract] [Full-text]
  204. Neural contrast sensitivity calculated from measured total contrast sensitivity and modulation transfer function.
    Acta Ophthalmol, 89(3): 278-83. [Abstract] [Full-text]
  205. Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization.
    Acta Ophthalmol, 89(3): 218-21. [Abstract] [Full-text]
  206. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema.
    Acta Ophthalmol, 89(3): 248-54. [Abstract] [Full-text]
  207. Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes.
    Acta Ophthalmol, 89(3): 222-8. [Abstract] [Full-text]
  208. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal.
    J Cell Physiol, 226(7): 1813-9. [Abstract] [Full-text]
  209. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
    J Immunol, 186(9): 5131-41. [Abstract] [Full-text]
  210. Mono-PEGylated dimeric exendin-4 as high receptor binding and long-acting conjugates for type 2 anti-diabetes therapeutics.
    Bioconjug Chem, 22(4): 625-32. [Abstract] [Full-text]
  211. Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure.
    Eur J Heart Fail, 13(5): 551-9. [Abstract] [Full-text]
  212. Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats.
    J Agric Food Chem, 59(8): 3747-53. [Abstract] [Full-text]
  213. The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study.
    QJM, 104(5): 403-10. [Abstract] [Full-text]
  214. Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan.
    Health Policy, 100(2): 196-202. [Abstract] [Full-text]
  215. The association between gestational diabetes mellitus and recreational physical activity.
    Matern Child Health J, 15(4): 514-9. [Abstract] [Full-text]
  216. Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations.
    Cancer, 117(9): 1812-8. [Abstract] [Full-text]
  217. Topic model for Chinese medicine diagnosis and prescription regularities analysis: case on diabetes.
    Chin J Integr Med, 17(4): 307-13. [Abstract] [Full-text]
  218. Effects of external application of Chinese medicine on diabetic ulcers and the expressions of β-catenin, c-myc and K6.
    Chin J Integr Med, 17(4): 261-6. [Abstract] [Full-text]
  219. The prevalence of asymptomatic and symptomatic peripheral arterial disease and peripheral arterial disease risk factors in the U.S. population.
    Holist Nurs Pract, 25(3): 147-61. [Abstract] [Full-text]
  220. Motor end plate innervation loss in diabetes and the role of insulin.
    J Neuropathol Exp Neurol, 70(5): 323-39. [Abstract] [Full-text]
  221. Nutrition in an ethnically diverse society: what are some of the key challenges?
    Proc Nutr Soc, 70(2): 252-62. [Abstract] [Full-text]
  222. Preventing diabetes and obesity in American Indian communities: the potential of environmental interventions.
    Am J Clin Nutr, 93(5): 1179S-83S. [Abstract] [Full-text]
  223. Lipid control in patients with diabetes mellitus.
    Nat Rev Cardiol, 8(5): 278-90. [Abstract] [Full-text]
  224. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.
    Hypertension, 57(5): 891-7. [Abstract] [Full-text]
  225. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).
    Transplantation, 91(9): 976-83. [Abstract] [Full-text]
  226. Does vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans?
    Am J Clin Nutr, 93(5): 1175S-8S. [Abstract] [Full-text]
  227. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.
    Am J Clin Nutr, 93(5): 1087-91. [Abstract] [Full-text]
  228. The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus.
    Diabetes Obes Metab, 13(6): 542-50. [Abstract] [Full-text]
  229. Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks.
    Diabetes Obes Metab, 13(6): 567-76. [Abstract] [Full-text]
  230. Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment.
    Diabetes Obes Metab, 13(6): 523-32. [Abstract] [Full-text]
  231. Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.
    Arterioscler Thromb Vasc Biol, 31(5): 1192-200. [Abstract] [Full-text]
  232. Comparison of the relationships of alcohol intake with atherosclerotic risk factors in men with and without diabetes mellitus.
    Alcohol Alcohol, 46(3): 301-7. [Abstract] [Full-text]
  233. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
    Diabetes Obes Metab, 13(6): 533-41. [Abstract] [Full-text]
  234. A cohort study of acute pancreatitis in relation to exenatide use.
    Diabetes Obes Metab, 13(6): 559-66. [Abstract] [Full-text]
  235. Pregnancy in women with Type 1 and Type 2 diabetes in Dublin.
    Ir J Med Sci, 180(2): 469-73. [Abstract] [Full-text]
  236. Tissue kallikrein inhibits retinal neovascularization via the cleavage of vascular endothelial growth factor-165.
    Arterioscler Thromb Vasc Biol, 31(5): 1041-8. [Abstract] [Full-text]
  237. Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.
    Diabetes Obes Metab, 13(6): 498-504. [Abstract] [Full-text]
  238. Insulin dose-response studies in severely insulin-resistant type 2 diabetes--evidence for effectiveness of very high insulin doses.
    Diabetes Obes Metab, 13(6): 511-6. [Abstract] [Full-text]
  239. Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes.
    Diabetes Obes Metab, 13(6): 505-10. [Abstract] [Full-text]
  240. Interventions in primary care to improve cardiovascular risk factors and glycated haemoglobin (HbA1c) levels in patients with diabetes: a systematic review.
    Diabetes Obes Metab, 13(6): 479-89. [Abstract] [Full-text]
  241. Risk factors for progression of subclinical diabetic macular oedema.
    Br J Ophthalmol, 95(5): 671-4. [Abstract] [Full-text]
  242. Vascular stem cells and ischaemic retinopathies.
    Prog Retin Eye Res, 30(3): 149-66. [Abstract] [Full-text]
  243. Two common genetic variants near nuclear-encoded OXPHOS genes are associated with insulin secretion in vivo.
    Eur J Endocrinol, 164(5): 765-71. [Abstract] [Full-text]
  244. Systemic causes of abdominal pain.
    Emerg Med Clin North Am, 29(2): 195-210, vii. [Abstract] [Full-text]
  245. Coping skills training in a telephone health coaching program for youth at risk for type 2 diabetes.
    J Pediatr Health Care, 25(3): 153-61. [Abstract] [Full-text]
  246. Induction of ischemic tolerance protects the retina from diabetic retinopathy.
    Am J Pathol, 178(5): 2264-74. [Abstract] [Full-text]
  247. Impaired biomechanical properties of diabetic skin implications in pathogenesis of diabetic wound complications.
    Am J Pathol, 178(5): 2215-23. [Abstract] [Full-text]
  248. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.
    Am J Pathol, 178(5): 2205-14. [Abstract] [Full-text]
  249. A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.
    Am J Pathol, 178(5): 2136-45. [Abstract] [Full-text]
  250. Natural progression of cardiac autonomic neuropathy in patients with type 1 diabetes: a four-year follow-up study.
    Anadolu Kardiyol Derg, 11(3): 224-31. [Abstract] [Full-text]
  251. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor.
    Biomaterials, 32(18): 4243-54. [Abstract] [Full-text]
  252. Retrograde ankle arthrodesis using an intramedullary nail: a comparison of patients with and without diabetes mellitus.
    J Foot Ankle Surg, 50(3): 299-306. [Abstract] [Full-text]
  253. Thymoquinone ameliorates chemical induced oxidative stress and β-cell damage in experimental hyperglycemic rats.
    Chem Biol Interact, 190(2): 148-54. [Abstract] [Full-text]
  254. Cardiovascular disease in recent onset diabetes mellitus.
    J Cardiol, 57(3): 257-62. [Abstract] [Full-text]
  255. Effect of streptozocin-induced diabetes mellitus on expression of methionine sulfoxide reductases and accumulation of their substrates in mouse lenses.
    Exp Eye Res, 92(5): 401-7. [Abstract] [Full-text]
  256. Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats.
    Physiol Behav, 103(3): 284-9. [Abstract] [Full-text]
  257. Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.
    Pharmacol Res, 63(5): 383-8. [Abstract] [Full-text]
  258. A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
    Mol Genet Metab, 103(1): 66-70. [Abstract] [Full-text]
  259. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.
    Free Radic Biol Med, 50(10): 1400-9. [Abstract] [Full-text]
  260. Cellular changes in diabetic and idiopathic gastroparesis.
    Gastroenterology, 140(5): 1575-85.e8. [Abstract] [Full-text]
  261. PPARβ/δ activation induces enteroendocrine L cell GLP-1 production.
    Gastroenterology, 140(5): 1564-74. [Abstract] [Full-text]
  262. Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.
    Mol Genet Metab, 103(1): 60-5. [Abstract] [Full-text]
  263. Design of potent and selective GPR119 agonists for type II diabetes.
    Bioorg Med Chem Lett, 21(9): 2665-9. [Abstract] [Full-text]
  264. Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients.
    Free Radic Biol Med, 50(10): 1215-21. [Abstract] [Full-text]
  265. Effects of treatment with St. John's Wort on blood glucose levels and pain perceptions of streptozotocin-diabetic rats.
    Fitoterapia, 82(4): 576-84. [Abstract] [Full-text]
  266. Targeting parathyroid hormone level in diabetic patients with stage 3 to 5 chronic kidney disease: does metabolic syndrome matter?
    J Ren Nutr, 21(3): 219-25. [Abstract] [Full-text]
  267. Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways.
    BJU Int, 107(10): 1676-84. [Abstract] [Full-text]
  268. Presentation and course of diabetes in children and adolescents with Alstrom syndrome.
    Pediatr Diabetes, 12(3): 270-5. [Abstract] [Full-text]
  269. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
    Pediatr Diabetes, 12(3): 192-6. [Abstract] [Full-text]
  270. Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children.
    Pediatr Diabetes, 12(3): 142-9. [Abstract] [Full-text]
  271. Effect of pregnancy and diabetes on vascular receptors for angiotensin II.
    Clin Exp Hypertens, 33(3): 167-73. [Abstract] [Full-text]
  272. Recurrent hypoglycemia exacerbates cerebral ischemic damage in streptozotocin-induced diabetic rats.
    Stroke, 42(5): 1404-11. [Abstract] [Full-text]
  273. Assessing diabetes support in adolescents: factor structure of the Modified Diabetes Social Support Questionnaire (M-DSSQ-Family).
    Pediatr Diabetes, 12(3): 258-65. [Abstract] [Full-text]
  274. Obesity and type 2 diabetes mellitus in a birth cohort of First Nation children born to mothers with pediatric-onset type 2 diabetes.
    Pediatr Diabetes, 12(3): 219-28. [Abstract] [Full-text]
  275. Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions.
    Apoptosis, 16(5): 478-90. [Abstract] [Full-text]
  276. Morphofunctional evaluation of thymus in hyperglycemic-hypoinsulinemic mice during dermatophytic infection.
    FEMS Immunol Med Microbiol, 62(1): 32-40. [Abstract] [Full-text]
  277. Diabetes mellitus alters the mechanical properties of the native tendon in an experimental rat model.
    J Orthop Res, 29(6): 880-5. [Abstract] [Full-text]
  278. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2.
    Obesity (Silver Spring), 19(5): 1010-8. [Abstract] [Full-text]
  279. The Environmental Determinants of Diabetes in the Young (TEDDY) study: predictors of early study withdrawal among participants with no family history of type 1 diabetes.
    Pediatr Diabetes, 12(3): 165-71. [Abstract] [Full-text]
  280. Variants in the CD36 gene locus determine whole-body adiposity, but have no independent effect on insulin sensitivity.
    Obesity (Silver Spring), 19(5): 1004-9. [Abstract] [Full-text]
  281. Low zinc in drinking water is associated with the risk of type 1 diabetes in children.
    Pediatr Diabetes, 12(3): 156-64. [Abstract] [Full-text]
  282. Increased mitochondrial oxidative phosphorylation in the liver is associated with obesity and insulin resistance.
    Obesity (Silver Spring), 19(5): 917-24. [Abstract] [Full-text]
  283. Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Med Sci Sports Exerc, 43(5): 770-8. [Abstract] [Full-text]
  284. Lifestyle change diminishes a hypertensive response to exercise in type 2 diabetes.
    Med Sci Sports Exerc, 43(5): 764-9. [Abstract] [Full-text]
  285. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes.
    Pediatr Diabetes, 12(3): 177-82. [Abstract] [Full-text]
  286. Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web-survey.
    Pediatr Diabetes, 12(3): 172-6. [Abstract] [Full-text]
  287. Parenteral insulin suppresses T cell proliferation to islet antigens.
    Pediatr Diabetes, 12(3): 150-5. [Abstract] [Full-text]
  288. Methods for the cultural adaptation of a diabetes lifestyle intervention for Latinas: an illustrative project.
    Health Promot Pract, 12(3): 341-8. [Abstract] [Full-text]
  289. In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18.
    Eur J Immunol, 41(5): 1344-51. [Abstract] [Full-text]
  290. TLR2 signaling improves immunoregulation to prevent type 1 diabetes.
    Eur J Immunol, 41(5): 1399-409. [Abstract] [Full-text]
  291. Dietary saury oil reduces hyperglycemia and hyperlipidemia in diabetic KKAy mice and in diet-induced obese C57BL/6J mice by altering gene expression.
    Lipids, 46(5): 425-34. [Abstract] [Full-text]
  292. The vasorelaxant effect of hydrogen sulfide is enhanced in streptozotocin-induced diabetic rats.
    Naunyn Schmiedebergs Arch Pharmacol, 383(5): 509-17. [Abstract] [Full-text]
  293. Weight and inflammation are the major determinants of vascular dysfunction in the aortae of db/db mice.
    Naunyn Schmiedebergs Arch Pharmacol, 383(5): 483-92. [Abstract] [Full-text]
  294. Shortened {beta}-cell lifespan leads to {beta}-cell deficit in a rodent model of type 2 diabetes.
    Am J Physiol Endocrinol Metab, 300(5): E933-8. [Abstract] [Full-text]
  295. Body composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome.
    Acta Paediatr, 100(6): 871-7. [Abstract] [Full-text]
  296. Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys.
    Am J Physiol Endocrinol Metab, 300(5): E894-901. [Abstract] [Full-text]
  297. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Am J Physiol Endocrinol Metab, 300(5): E923-32. [Abstract] [Full-text]
  298. The change of plasma ghrelin and leptin levels by the development of type 2 diabetes mellitus in patients with alcohol dependence.
    Alcohol Clin Exp Res, 35(5): 905-11. [Abstract] [Full-text]
  299. Change of erectile function and responsiveness to phosphodiesterase type 5 inhibitors at different stages of streptozotocin-induced diabetes in rats.
    J Sex Med, 8(5): 1352-61. [Abstract] [Full-text]
  300. Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats.
    Biol Trace Elem Res, 140(3): 342-53. [Abstract] [Full-text]
  301. Benefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategies.
    Diabetes Care, 34: S297-303. [Abstract] [Full-text]
  302. Therapy in the early stage: incretins.
    Diabetes Care, 34: S264-71. [Abstract] [Full-text]
  303. Type 2 diabetes can be prevented with early pharmacological intervention.
    Diabetes Care, 34: S202-9. [Abstract] [Full-text]
  304. The genetic effect of copy number variations on the risk of type 2 diabetes in a Korean population.
    PLoS One, 6(4): e19091. [Abstract] [Full-text]
  305. Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy.
    PLoS One, 6(4): e18671. [Abstract] [Full-text]
  306. Fractalkine is a novel human adipochemokine associated with type 2 diabetes.
    Diabetes, 60(5): 1512-8. [Abstract] [Full-text]
  307. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies.
    Diabetes Care, 34(5): 1238-44. [Abstract] [Full-text]
  308. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis.
    Diabetes Care, 34(5): 1228-37. [Abstract] [Full-text]
  309. Medical expenditures associated with diabetes among privately insured U.S. youth in 2007.
    Diabetes Care, 34(5): 1097-101. [Abstract] [Full-text]
  310. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes.
    Diabetes Care, 34(5): 1081-5. [Abstract] [Full-text]
  311. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss.
    Sci Transl Med, 3(80): 80re2. [Abstract] [Full-text]
  312. Two roads diverge: weight loss interventions and circulating amino acids.
    Sci Transl Med, 3(80): 80ps15. [Abstract] [Full-text]
  313. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    J Microbiol Immunol Infect, 44(3): 166-71. [Abstract] [Full-text]
  314. N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial.
    Cardiovasc Diabetol, 10: 28. [Abstract] [Full-text]
  315. Are the 2005 Dietary Guidelines for Americans Associated With reduced risk of type 2 diabetes and cardiometabolic risk factors? Twenty-year findings from the CARDIA study.
    Diabetes Care, 34(5): 1183-5. [Abstract] [Full-text]
  316. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
    Diabetes Care, 34(5): 1139-44. [Abstract] [Full-text]
  317. Competing demands for time and self-care behaviors, processes of care, and intermediate outcomes among people with diabetes: Translating Research Into Action for Diabetes (TRIAD).
    Diabetes Care, 34(5): 1180-2. [Abstract] [Full-text]
  318. Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes.
    Diabetes Care, 34(5): 1199-204. [Abstract] [Full-text]
  319. Diet-quality scores and the risk of type 2 diabetes in men.
    Diabetes Care, 34(5): 1150-6. [Abstract] [Full-text]
  320. Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling.
    Diabetes, 60(5): 1414-23. [Abstract] [Full-text]
  321. Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy.
    Diabetes Care, 34(5): 1192-8. [Abstract] [Full-text]
  322. First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus.
    Diabetes Care, 34(5): 1091-3. [Abstract] [Full-text]
  323. Functional sympatholysis during exercise in patients with type 2 diabetes with intact response to acetylcholine.
    Diabetes Care, 34(5): 1186-91. [Abstract] [Full-text]
  324. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
    Diabetes, 60(5): 1599-607. [Abstract] [Full-text]
  325. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes.
    Diabetes, 60(5): 1624-31. [Abstract] [Full-text]
  326. Multimodality imaging of β-cells in mouse models of type 1 and 2 diabetes.
    Diabetes, 60(5): 1383-92. [Abstract] [Full-text]
  327. Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump.
    Diabetes Care, 34(5): 1089-90. [Abstract] [Full-text]
  328. Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes.
    Diabetes Care, 34(5): 1114-9. [Abstract] [Full-text]
  329. Birth size distribution in 3,705 infants born to mothers with type 1 diabetes: a population-based study.
    Diabetes Care, 34(5): 1145-9. [Abstract] [Full-text]
  330. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.
    Diabetes Care, 34(5): 1211-3. [Abstract] [Full-text]
  331. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study).
    Diabetes Care, 34(5): 1133-8. [Abstract] [Full-text]
  332. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men.
    Diabetes, 60(5): 1608-16. [Abstract] [Full-text]
  333. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes.
    Diabetes Care, 34(5): 1164-70. [Abstract] [Full-text]
  334. Diabetes as a cause of clinically significant functional cobalamin deficiency.
    Diabetes Care, 34(5): 1077-80. [Abstract] [Full-text]
  335. Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group.
    Diabetes Care, 34(5): 1127-32. [Abstract] [Full-text]
  336. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.
    Diabetes, 60(5): 1552-60. [Abstract] [Full-text]
  337. Modeling the consistency of hypoglycemic symptoms: high variability in diabetes.
    Diabetes Technol Ther, 13(5): 571-8. [Abstract] [Full-text]
  338. Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats.
    Diabetes, 60(5): 1582-9. [Abstract] [Full-text]
  339. Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes.
    Diabetes, 60(5): 1474-7. [Abstract] [Full-text]
  340. Rhythmic diurnal gene expression in human adipose tissue from individuals who are lean, overweight, and type 2 diabetic.
    Diabetes, 60(5): 1577-81. [Abstract] [Full-text]
  341. Variants of GCKR affect both β-cell and kidney function in patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study 2.
    Diabetes Care, 34(5): 1205-10. [Abstract] [Full-text]
  342. Understanding physicians' challenges when treating type 2 diabetic patients' social and emotional difficulties: a qualitative study.
    Diabetes Care, 34(5): 1086-8. [Abstract] [Full-text]
  343. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study.
    Diabetes Care, 34(5): 1171-6. [Abstract] [Full-text]
  344. Ginseng and ginsenoside Re do not improve β-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes.
    Diabetes Care, 34(5): 1071-6. [Abstract] [Full-text]
  345. Risk of diabetes among young adults born preterm in Sweden.
    Diabetes Care, 34(5): 1109-13. [Abstract] [Full-text]
  346. Preliminary application of a new bolus insulin model for type 1 diabetes.
    Diabetes Technol Ther, 13(5): 527-35. [Abstract] [Full-text]
  347. Digital subtraction angiography and computed tomography angiography of predominant artery feeding pancreatic body and tail.
    Diabetes Technol Ther, 13(5): 537-41. [Abstract] [Full-text]
  348. Qualitative evaluation of a mobile phone and web-based collaborative care intervention for patients with type 2 diabetes.
    Diabetes Technol Ther, 13(5): 563-9. [Abstract] [Full-text]
  349. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance.
    Diabetes Technol Ther, 13(5): 501-7. [Abstract] [Full-text]
  350. Needle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity.
    Diabetes Technol Ther, 13(5): 579-85. [Abstract] [Full-text]
  351. The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements.
    Diabetes Technol Ther, 13(5): 592-5. [Abstract] [Full-text]
  352. Accuracy and precision evaluation of seven self-monitoring blood glucose systems.
    Diabetes Technol Ther, 13(5): 596-600. [Abstract] [Full-text]
  353. Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries.
    Diabetes Technol Ther, 13(5): 586-91. [Abstract] [Full-text]
  354. Contracting and monitoring relationships for adolescents with type 1 diabetes: a pilot study.
    Diabetes Technol Ther, 13(5): 543-9. [Abstract] [Full-text]
  355. Chat line for adolescents with type 1 diabetes: a useful tool to improve coping with diabetes: a 2-year follow-up study.
    Diabetes Technol Ther, 13(5): 551-5. [Abstract] [Full-text]
  356. Developing an objective evaluation method to estimate diabetes risk in community-based settings.
    Diabetes Technol Ther, 13(5): 557-61. [Abstract] [Full-text]
  357. Hydrodynamics-based transfection of the combination of betacellulin and neurogenic differentiation 1 DNA ameliorates hyperglycemia in mice with streptozotocin-induced diabetes.
    Diabetes Technol Ther, 13(5): 519-25. [Abstract] [Full-text]
  358. Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study.
    Diabetes Care, 34(5): 1219-24. [Abstract] [Full-text]
  359. Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan.
    Diabetes Care, 34(5): 1177-9. [Abstract] [Full-text]
  360. Diabetes-related distress and physical and psychological health in chinese type 2 diabetic patients.
    Diabetes Care, 34(5): 1094-6. [Abstract] [Full-text]
  361. FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies.
    Diabetes, 60(5): 1637-44. [Abstract] [Full-text]
  362. Beneficial effect of the leaves of Murraya koenigii (Linn.) Spreng (Rutaceae) on diabetes-induced renal damage in vivo.
    J Ethnopharmacol, 135(1): 88-94. [Abstract] [Full-text]
  363. Obesity, diabetes mellitus, and liver fibrosis.
    Am J Physiol Gastrointest Liver Physiol, 300(5): G697-702. [Abstract] [Full-text]
  364. Acute response of blood glucose to short-term exercise training in patients with type 2 diabetes.
    J Sci Med Sport, 14(3): 238-42. [Abstract] [Full-text]
  365. Maternal serum and cord blood preptin levels in gestational diabetes mellitus.
    J Perinatol, 31(5): 350-5. [Abstract] [Full-text]
  366. Induced L₂-norm minimization of glucose-insulin system for Type I diabetic patients.
    Comput Methods Programs Biomed, 102(2): 105-18. [Abstract] [Full-text]
  367. Physiologic insulin delivery with insulin feedback: a control systems perspective.
    Comput Methods Programs Biomed, 102(2): 130-7. [Abstract] [Full-text]
  368. Anticipating the next meal using meal behavioral profiles: a hybrid model-based stochastic predictive control algorithm for T1DM.
    Comput Methods Programs Biomed, 102(2): 138-48. [Abstract] [Full-text]
  369. Model-based decision support in diabetes care.
    Comput Methods Programs Biomed, 102(2): 206-18. [Abstract] [Full-text]
  370. Systematic method to assess microvascular recruitment using contrast-enhanced ultrasound. Application to insulin-induced capillary recruitment in subjects with T1DM.
    Comput Methods Programs Biomed, 102(2): 219-26. [Abstract] [Full-text]
  371. Tubular biomarkers to assess progression of diabetic nephropathy.
    Kidney Int, 79(10): 1042-4. [Abstract] [Full-text]
  372. Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity.
    Clin Chem, 57(5): 719-28. [Abstract] [Full-text]
  373. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes.
    Circ Res, 108(9): 1112-21. [Abstract] [Full-text]
  374. Effects of prediabetes on coronary collateral circulation in patients with coronary artery disease.
    Coron Artery Dis, 22(4): 233-7. [Abstract] [Full-text]
  375. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.
    Kidney Int, 79(10): 1090-8. [Abstract] [Full-text]
  376. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
    Kidney Int, 79(10): 1113-8. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2013 Diabetes Research Today. All Rights Reserved.



Diabetes Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)



Diabetes Books

Diabetes & Heart Healthy Meals for Two

Diabetes & Heart Healthy Meals for Two